000			01714 a2200481 4500
005			20250516145230.0
264		0	_c20130626
008			201306s 0 0 eng d
022			_a1107-0625
040			_aNLM _beng _cNLM
100	1		_aEkinci, D
245	0	0	_aThe role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy. _h[electronic resource]
260			_bJournal of B.U.ON. : official journal of the Balkan Union of Oncology _c
300			_a245-52 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdministration, Metronomic
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBevacizumab
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aCamptothecin _xadministration & dosage
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMethotrexate _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasms _xblood
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor A _xblood
700	1		_aEkici, D
700	1		_aKargi, A
700	1		_aYalcin, A D
700	1		_aDidem Yalcin, A
700	1		_aSavas, B
773	0		_tJournal of B.U.ON. : official journal of the Balkan Union of Oncology _gvol. 18 _gno. 1 _gp. 245-52
999			_c22695570 _d22695570